Company profile: Ablative Solutions
1.1 - Company Overview
Company description
- Provider of an alternative to surgical renal denervation for hypertension, offering the Peregrine System Kit, a transcatheter alcohol-mediated system delivering neurolytic solution to the perivascular space of the renal artery; the Peregrine System Infusion Catheter with three guided microneedles for targeted infusion into the perivascular area of the peripheral vasculature; and the TARGET BP clinical trials evaluating safety and efficacy for uncontrolled hypertension.
Products and services
- Peregrine System Infusion Catheter: Three-microneedle, guided catheter enabling targeted infusion of diagnostic and therapeutic agents into the perivascular area of the peripheral vasculature
- Peregrine System Kit: Transcatheter, alcohol-mediated renal denervation system that delivers a neurolytic solution into the perivascular space of the renal artery to ablate nerves influencing blood pressure regulation
- TARGET BP Clinical Trial Program: Clinical-trial program conducting a series of studies assessing the safety and efficacy of the Peregrine System Kit for treating uncontrolled hypertension via renal denervation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ablative Solutions
Baylis Medical
HQ: Canada
Website
- Description: Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baylis Medical company profile →
Vascular Dynamics
HQ: United States
Website
- Description: Provider of the MobiusHD endovascular implant and catheter-based EVBA procedure to modulate the baroreflex via carotid sinus placement, aiming to correct inflexible arterial motion to treat hypertension and restore autonomic balance in heart failure patients; also conducts clinical research evaluating the safety and effectiveness of MobiusHD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Dynamics company profile →
Synaptic Medical
HQ: United States
Website
- Description: Provider of medical devices for cryoablation and cardiac procedures, including the Nordica Cryo Console and Nordica Balloon Catheter (both under investigation), a Pulmonary Vein Mapping Catheter, NaviGo 12F and NaviEase intracardiac catheter introducer kits, and the AKS Transseptal Needle for transseptal access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synaptic Medical company profile →
Scanadu
HQ: United States
Website
- Description: Provider of mobile medical devices, including Scanadu Scout for checking vital signs and Scanaflo, an at-home urine analysis test with results viewable on a smartphone.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scanadu company profile →
Xeltis
HQ: The Netherlands
Website
- Description: Provider of polymer-based restorative cardiovascular devices, including implantable small-diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft surgery, and pulmonary heart valves. Products include aXess; XABG/Xabg; and Xplore-2, designed to transform into a living valve made of the patient’s own tissue, aiming to reduce reintervention rates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xeltis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ablative Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ablative Solutions
2.2 - Growth funds investing in similar companies to Ablative Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ablative Solutions
4.2 - Public trading comparable groups for Ablative Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →